Generation Bio
Engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases.
Launch date
Employees
Market cap
CAD237m
Enterprise valuation
CAD69m (Public information from Sep 2024)
Share price
$2.86 GBIO
Cambridge Massachusetts (HQ)
Authorizing premium user...